Immunosyn Corporation (IMYN.OB) Refutes Unfounded Rumors in Marketplace
9/21/2009 8:51:13 AM
More...
|
Dr. Myron Wentz Resigns from Immunosyn Corporation (IMYN.OB) Board of Directors
3/23/2009 9:47:08 AM
More...
|
Immunosyn Corporation (IMYN.OB) Announces 2008 Results
3/19/2009 12:00:09 PM
More...
|
Immunosyn Corporation (IMYN.OB) Files 10-Q
11/18/2008 8:58:05 AM
More...
|
Immunosyn Corporation (IMYN.OB) Files 10-Q
8/14/2008 11:12:48 AM
More...
|
Immunosyn Corporation (IMYN.OB) Release: SF-1019 Receives Approval for Treatment, Marketing and Distribution in Malaysia
8/12/2008 8:56:14 AM
More...
|
Immunosyn Corporation (IMYN.OB) Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
7/16/2008 9:12:59 AM
More...
|
Immunosyn Corporation (IMYN.OB) Announces 2007 Results, Files 10KSB
4/1/2008 7:56:10 AM
More...
|
Myron W. Wentz, Ph.D. Elected to Serve on Immunosyn Corporation (IMYN.OB)'s Board of Directors
3/17/2008 8:14:34 AM
More...
|
Immunosyn Corporation (IMYN.OB) Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
2/26/2008 8:46:11 AM
More...
|
|